![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, February 23, 2013 5:47:05 PM
DrFeelgood Member Profile DrFeelgood Member Level
Saturday, February 23, 2013 5:31:11 PM
Re: Brenum post# 25146
Post # of 25148
Much of that process does not apply to Kevetrin or Prurisol, if both work as expected. With excellent Phase 1 results, Kevetrin will qualify for unmet need against stage 4 highly resistant solid tumor cancers. At the least, it will jump from Phase 1 to Phase 3 since much of Phase 2 is already designed into the current trial. Best case, if Phase 1 results align with animal efficacy and tox studies, it will be designated a breakthrough therapy and immediately approved for clinical use and marketing against high resistance tumors, without further testing.
Prurisol is already entering Phase 2/3a testing in Europe, and with decent results there, should be approved for pivotal Phase 3 testing in the US. So, both drugs are farther advanced in the human testing process than the FDA "Drug Review Process" would indicate.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
Mawson Finland Provides Update on Exploration Activities at Rajapalot • MFL • Aug 21, 2024 9:06 AM
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM